About BioCytics
BioCytics is a private company based in Huntersville, North Carolina. It has reported $1,405,000 raised in three offerings on Form D since March 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 2, 2026 | Mar 13, 2026 | $25,000of $7.0M target | 1 | $25,000 | OptionsRule 506(b) | Form D ↗ |
| Dec 15, 2023 | Dec 28, 2023 | $25,000of $4.0M target | 1 | $25,000 | OptionsRule 506(b) | Form D ↗ |
| Feb 8, 2023 | Mar 31, 2023 | $1,355,000of $8.0M target | 18 | $75,278 | OptionsRule 506(b) | Form D ↗ |
| Total, three offerings | $1,405,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on BioCytics's Form D filed Mar 13, 2026.
Earlier filings also listed Stacy Powderly (executive officer, last listed Dec 2023), Don Jackson (chief operating officer, last listed Dec 2023) and Matthew Pietras (cfo and assistant secretary, last listed Mar 2023).